Skip to main content

Hyperliquid Strategies Inc

corporate_fare Company Profile

Hyperliquid Strategies Inc

Hyperliquid Strategies Inc., through its subsidiary, operates as a a biotechnology company that owns a platform for biologic medicines of single or bifunctional action. The company was incorporated in 2025 and is based in New York, New York.

Exchange: NASDAQSector: Crypto Assets

show_chartPrice Chart

Loading chart...

feed PURR - Latest Insights

PURR
Feb 17, 2026, 7:18 PM EST
Filing Type: 8-K/A
Importance Score:
9
Hyperliquid Strategies Files Pro Forma Financials for Sonnet Acquisition, Revealing Significant HYPE Token Loss and IPR&D Expensing
Sentiment: Negative
View Wiseek Article
PURR
Feb 11, 2026, 11:55 AM EST
Filing Type: 10-Q
Importance Score:
8
Hyperliquid Strategies Reports Substantial Q2 Losses Driven by HYPE Digital Asset Declines, Secures New Capital & Alleviates Going Concern
Sentiment: Negative
View Wiseek Article
PURR
Feb 11, 2026, 7:25 AM EST
Filing Type: 8-K
Importance Score:
8
Hyperliquid Strategies Reports Q2 Loss Amid HYPE Volatility, Continues Share Buybacks and Token Acquisitions
Sentiment: Neutral
View Wiseek Article